According to the lawsuit, throughout the Class Period and in the SPO Materials, defendants misled investors about agilon’s medical costs by:
- touting agilon’s purported visibility into utilization trends and medical costs;
- failing to disclose increased medical costs that agilon had incurred prior to and during the Class Period due to higher utilization of healthcare by Medicare Avantage (“MA”) patients;
- falsely stating that its accounting reserves for higher-than-expected medical costs were adequate;
- making false and misleading statements about the effectiveness of its business model;
- issuing overly optimistic financial guidance; and
- issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.
